Goldfinch Bio has its wings clipped, shutting down after 7 years
Jan 27, 2023 · Goldfinch Bio, a 2020 Fierce Biotech Fierce 15 winner, is shutting down. CEO Tony Johnson and Chief Financial and Operating Officer Kyle Kuvalanka told Fierce Biotech …
What Happened To Goldfinch Bio & Why Did It Fail?
Goldfinch Bio, founded in 2016, aimed to develop therapies for progressive kidney diseases. Despite initial success and significant investments, the company faced funding challenges and …
Goldfinch shuts down, Karuna snaps up drug candidates
Feb 10, 2023 · Karuna Therapeutics is snapping up assets from Goldfinch Bio, a developer of kidney disease medicine that is closing its doors.
Karuna, hoping to find new brain drugs, buys up a shuttering …
Feb 2, 2023 · Through a deal announced Thursday, Karuna will get an exclusive global license to develop, manufacture and market these medicines from Goldfinch Bio, which target a type of …
Goldfinch Bio Shutting Down - Global Genes
Jan 30, 2023 · Goldfinch Bio, which raised $100 million in 2020 to advance development of experimental therapies for rare and metabolic kidney diseases, is shutting down after it was …
Goldfinch Bio Announces Positive Preliminary Data from Phase 2 …
Feb 28, 2022 · Goldfinch Bio, Inc. is a clinical stage biotechnology company focused on delivering disease-modifying precision medicines that bring hope and renewed quality of life to people …
Goldfinch Bio - LinkedIn
Thanks to a growing understanding of kidney biology and genetics, including pioneering research by the founders of Goldfinch, the scientific community is starting to understand the …
Kidney disease drugmaker Goldfinch Bio shuts down - Endpoints …
Jan 27, 2023 · Goldfinch Bio, attempting to make treatments for kidney diseases and diabetic nephropathy, is shutting down. President and CEO Tony Johnson confirmed to Endpoints …
Karuna plunders Goldfinch’s nest to pad neuroscience pipeline
Feb 2, 2023 · For $15 million upfront, Karuna has secured Goldfinch’s transient receptor potential canonical 4 and 5 (TRPC4/5) channel candidates, including lead asset GFB-887, which has …
Goldfinch Bio falls from the sky after failing to find a path forward ...
Mar 13, 2023 · Goldfinch Bio, a 2020 Fierce Biotech Fierce 15 winner, is shutting down. CEO Tony Johnson and Chief Financial and Operating Officer Kyle Kuvalanka told Fierce Biotech …